Activation of immune cells increased the expression of the PD-1/PD-L1 immune checkpoint inhibitors and restored or even enhanced the ability of immune cells to kill tumor cells by blocking PD-1/PD-L1 expression (19). This evidence concerns the gene CD274 and neoplasm.